Is a Heavy Tech Burden the Price of Progress for Sites?
State of Digital Clinical Trials Podcast10/31/24 • 52 min
Richard Young passes the torch to Manny Vazquez, our new podcast host, and shares his reflections before turning off his mic for the final time. Later, Manny is joined by renowned industry thinker and site leader Brad Hightower, owner of clinical research center Hightower Clinical in Oklahoma.
They discuss whether the growing tech burden is the price of progress for sites, plus tips on how sponsors can make sites’ lives easier. Brad also explains a few implications of the recent FDA draft guidance on DCTs and the upcoming site conference he helped to set up, ‘Save Our Sites’.
10/31/24 • 52 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/state-of-digital-clinical-trials-podcast-556028/is-a-heavy-tech-burden-the-price-of-progress-for-sites-77529647"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to is a heavy tech burden the price of progress for sites? on goodpods" style="width: 225px" /> </a>
Copy